NDC 60940-022

Triferic Solution for Hemodialysis

Ferric Pyrophosphate Citrate

Triferic Solution for Hemodialysis is a Intravenous Solution in the Human Prescription Drug category. It is labeled and distributed by Holopack Verpackungstechnik Gmgh. The primary component is Ferric Pyrophosphate Citrate.

Product ID60940-022_cf6f526d-9b1d-ff28-e053-2a95a90a681a
NDC60940-022
Product TypeHuman Prescription Drug
Proprietary NameTriferic Solution for Hemodialysis
Generic NameFerric Pyrophosphate Citrate
Dosage FormSolution
Route of AdministrationINTRAVENOUS
Marketing Start Date2020-06-02
Marketing CategoryNDA /
Application NumberNDA212860
Labeler NameHolopack Verpackungstechnik GmgH
Substance NameFERRIC PYROPHOSPHATE CITRATE
Active Ingredient Strength2 mg/mL
Pharm ClassesIron [CS],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 60940-022-01

8 POUCH in 1 CARTON (60940-022-01) > 10 AMPULE in 1 POUCH > 4.5 mL in 1 AMPULE
Marketing Start Date2020-06-02
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Triferic Solution for Hemodialysis" or generic name "Ferric Pyrophosphate Citrate"

NDCBrand NameGeneric Name
60940-022Triferic Solution for Hemodialysisferric pyrophosphate citrate
57278-315TrifericFERRIC PYROPHOSPHATE CITRATE
57278-316TrifericFerric Pyrophosphate Citrate
64811-315TrifericFERRIC PYROPHOSPHATE CITRATE
57278-318Triferic AVNUferric pyrophosphate citrate
60940-029Triferic AVNUferric pyrophosphate citrate

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.